Evidence map›Paper›PMID 37342372›Full record

ArticleAdvanced pharmaceutical bulletin2023

Optimized Signal Peptide for Secretory Expression of Human Recombinant Somatropin in

Zeynab Ahmadi, Safar Farajnia, Davoud Farajzadeh, Naser Pouladi, Neda Pourvatan, Mohammad Karbalaeimahdi, Fahime Shayegh, Maryam Arya

Open access · diamondAbstract read
In one paragraph

Article in Advanced pharmaceutical bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Zeynab AhmadiDepartment of Biology, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran.ORCID https://orcid.org/0009-0007-6796-8656
Safar FarajniaDrug Applied Research Center, Tabriz University of Medical Science, Tabriz, Iran.ORCID https://orcid.org/0000-0002-6087-9147
Davoud FarajzadehDepartment of Biology, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran.ORCID https://orcid.org/0000-0002-9267-4277
Naser PouladiDepartment of Biology, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran.
Neda PourvatanImmunology Research Center, Tabriz University of Medical Science, Tabriz, Iran.
Mohammad KarbalaeimahdiBiotechnology Research Center, Tabriz University of Medical Science, Tabriz, Iran.
Fahime ShayeghDrug Applied Research Center, Tabriz University of Medical Science, Tabriz, Iran.
Maryam AryaBiotechnology Research Center, Tabriz University of Medical Science, Tabriz, Iran.
Azarbaijan Shahid Madani University · IRTabriz University of Medical Sciences · IRUniversity of Tabriz · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

E. coliHuman somatropinSecretary expressionSignal peptide

Identifiers

PMID37342372
PMCPMC10278209
OpenAlexW4292234654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.